Columns: 1: chrom, 2: pos, 3: ref, 4: alt, 5: start, 6: stop, 7: strand, 8: variation_type, 9: variation_id, 10: rcv, 11: scv, 12: allele_id, 13: symbol, 14: hgvs_c, 15: hgvs_p, 16: molecular_consequence, 17: clinical_significance, 18: clinical_significance_ordered, 19: pathogenic, 20: likely_pathogenic, 21: uncertain_significance, 22: likely_benign, 23: benign, 24: review_status, 25: review_status_ordered, 26: last_evaluated, 27: all_submitters, 28: submitters_ordered, 29: all_traits, 30: all_pmids, 31: inheritance_modes, 32: age_of_onset, 33: prevalence, 34: disease_mechanism, 35: origin, 36: xrefs, 37: dates_ordered, 38: gold_stars, 39: conflicted,
================
Total rows: 293882
================
column 8: variation_type
Variant      293881
Haplotype         1
Name: variation_type, dtype: int64
================
column 17: clinical_significance
Uncertain significance                                                           119213
Likely benign                                                                     51935
Pathogenic                                                                        44663
Benign                                                                            23341
Likely pathogenic                                                                 14667
Conflicting interpretations of pathogenicity                                      12418
Benign/Likely benign                                                              10680
not provided                                                                      10654
Pathogenic/Likely pathogenic                                                       3034
other                                                                              1792
risk factor                                                                         395
drug response                                                                       261
association                                                                         134
Affects                                                                              95
Pathogenic, other                                                                    92
Pathogenic, risk factor                                                              77
Conflicting interpretations of pathogenicity, risk factor                            45
protective                                                                           26
Benign, risk factor                                                                  26
Pathogenic, drug response                                                            26
Likely pathogenic, risk factor                                                       24
Likely benign, risk factor                                                           22
Benign, other                                                                        22
Benign/Likely benign, risk factor                                                    21
Pathogenic/Likely pathogenic, risk factor                                            20
Uncertain significance, risk factor                                                  19
Uncertain significance, drug response                                                16
Conflicting interpretations of pathogenicity, other                                  14
Likely pathogenic, drug response                                                     11
Benign/Likely benign, other                                                           9
                                                                                  ...  
Likely benign, protective                                                             2
Benign/Likely benign, not provided                                                    2
Benign/Likely benign, Affects                                                         2
Likely pathogenic, association                                                        2
Pathogenic, other, protective                                                         2
Conflicting interpretations of pathogenicity, association, other, risk factor         2
Likely benign, association                                                            2
Benign, protective, risk factor                                                       1
Pathogenic/Likely pathogenic, Affects, risk factor                                    1
Benign, drug response, risk factor                                                    1
Pathogenic, association, protective                                                   1
Conflicting interpretations of pathogenicity, Affects, association, other             1
Uncertain significance, association                                                   1
Benign, drug response                                                                 1
Benign/Likely benign, protective, risk factor                                         1
Likely benign, drug response                                                          1
Benign, association, protective                                                       1
Likely benign, Affects                                                                1
Conflicting interpretations of pathogenicity, other, risk factor                      1
Benign/Likely benign, drug response, risk factor                                      1
Uncertain significance, Affects                                                       1
Likely pathogenic, Affects                                                            1
Pathogenic/Likely pathogenic, not provided                                            1
Benign, association, risk factor                                                      1
Affects, risk factor                                                                  1
Uncertain significance, protective                                                    1
Benign, Affects                                                                       1
Pathogenic, protective, risk factor                                                   1
Benign/Likely benign, drug response                                                   1
Conflicting interpretations of pathogenicity, Affects, other                          1
Name: clinical_significance, dtype: int64
================
column 24: review_status
criteria provided, single submitter                     194962
criteria provided, multiple submitters, no conflicts     34091
no assertion criteria provided                           33088
criteria provided, conflicting interpretations           12370
no assertion provided                                    10650
reviewed by expert panel                                  8601
no assertion for the individual variant                     95
practice guideline                                          23
-                                                            2
Name: review_status, dtype: int64
================
column 38: gold_stars
1    186596
0     38781
2     30141
1     20736
3      5596
0      5052
2      3950
3      3005
4        23
-         2
Name: gold_stars, dtype: int64
================
column 27: all_submitters
Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        75174
GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                38793
Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               20773
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 14625
OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  14278
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            8844
Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         8053
Genetic Services Laboratory, University of Chicago                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     7794
PreventionGenetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     4867
GeneReviews                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2337
Counsyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                2191
PreventionGenetics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1952
GeneDx;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1801
Ambry Genetics;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1564
ITMI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1485
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1458
Illumina Clinical Services Laboratory,Illumina;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1441
Invitae;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1332
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1254
Tuberous sclerosis database (TSC2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1186
InSiGHT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1178
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1146
Retina International                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1049
Systems Biology Platform Zhejiang California International NanoSystems Institute                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1004
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      994
Praxis fuer Humangenetik Tuebingen,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     963
GeneReviews;OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        938
ARUP Institute,ARUP Laboratories                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        937
Ambry Genetics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   927
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             920
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      ...  
OMIM;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Counsyl;Invitae;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
OMIM;Invitae;Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;Cardiovascular Research Group,Instituto Nacional de Saude Doutor Ricardo Jorge;Laboratory of Genetics and Molecular Cardiology,University of São Paulo;Robarts Research Institute,University of Western Ontario;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                       1
GeneDx;ITMI;Genetic Services Laboratory, University of Chicago;Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics;Invitae;Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
Texas Scottish Rite Hospital for Children;OMIM;GeneReviews;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
OMIM;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Developmental Genetics Unit,King Faisal Specialist Hospital & Research Centre;Ambry Genetics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
OMIM;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;ARUP Institute,ARUP Laboratories;Database of Curated Mutations (DoCM);GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
GeneReviews;OMIM;Juha Muilu Group, Institute for Molecular Medicine Finland (FIMM);SNPedia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1
Department of Medical Sciences,Uppsala University;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
Division of Human Genetics,Children's Hospital of Philadelphia;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1
OMIM;Pathway Genomics;Ambry Genetics;GeneDx;Database of Curated Mutations (DoCM);Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1
GeneReviews;PreventionGenetics;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Illumina Clinical Services Laboratory,Illumina;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP);OMIM;GeneDx;Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Centre for Mendelian Genomics,University Medical Centre Ljubljana                                                                                                                                                                                                                                                                                                                  1
Breast Cancer Information Core (BIC) (BRCA2);Fulgent Genetics;Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Sharing Clinical Reports Project (SCRP);Counsyl;Research Molecular Genetics Laboratory,Women's College Hospital, University of Toronto;Invitae;Ambry Genetics;GeneDx                                                                                                                                                                                                                                                                                                               1
GeneReviews;OMIM;UniProtKB/Swiss-Prot;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1
Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Sharing Clinical Reports Project (SCRP);Quest Diagnostics Nichols Institute San Juan Capistrano,;Research Molecular Genetics Laboratory,Women's College Hospital, University of Toronto;Department of Pathology and Laboratory Medicine,Sinai Health System;Invitae;Ambry Genetics;GeneDx                                                                                                                         1
Breast Cancer Information Core (BIC) (BRCA2);Sharing Clinical Reports Project (SCRP);Ambry Genetics;Invitae;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Department of Pathology and Laboratory Medicine,Sinai Health System                                                                                                                                                                                                                                                                                                                                                                                              1
Soonchunhyang University Bucheon Hospital,Soonchunhyang University Medical Center;ClinVar Staff, National Center for Biotechnology Information (NCBI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
Department of Mental Retardation and Birth Defect Research,  National Center of Neurology and Psychiatry;OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1
University of Washington Department of Laboratory Medicine,University of Washington;InSiGHT;Department of Pathology and Laboratory Medicine,Sinai Health System;Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
Tuberous sclerosis database (TSC2);Illumina Clinical Services Laboratory,Illumina;Ambry Genetics;Invitae;PreventionGenetics;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine                                                                                                                                                                                                                                                                                                                                                                                                                                   1
Invitae;Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Laboratory of Genomics and Molecular Biology,A. C. Camargo Cancer Center                                                                                                                                                                                                                                                                                                                                  1
PreventionGenetics;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Color Genomics, Inc.,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
Baylor Miraca Genetics Laboratories;Invitae;GeneReviews;OMIM;Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Greenwood Genetic Center Diagnostic Laboratories,Greenwood Genetic Center;Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP);Institute of Molecular Biology and Genetics,Federal Almazov North-West Medical Research Centre;ARUP Laboratories, Molecular Genetics and Genomics;Blueprint Genetics;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Ambry Genetics        1
Toronto General Hospital,University of Toronto                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
PreventionGenetics;ITMI;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
Institute for Clinical Genetics, TU Dresden                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1
GeneReviews;OMIM;Illumina Clinical Services Laboratory,Illumina;Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Invitae                                                                                                                                                                                                                                                                                                                                  1
Database of Curated Mutations (DoCM);OMIM;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;ARUP Institute,ARUP Laboratories;GeneDx;Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
OMIM;Athena Diagnostics Inc;Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children;Invitae;GeneReviews;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1
Breast Cancer Information Core (BIC) (BRCA2);Fulgent Genetics;Sharing Clinical Reports Project (SCRP);Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1
Name: all_submitters, dtype: int64
================
column 31: inheritance_modes
Autosomal dominant inheritance                                                                                                59898
Autosomal recessive inheritance                                                                                               24816
Autosomal dominant inheritance;Autosomal recessive inheritance                                                                 2911
X-linked inheritance                                                                                                           2386
Autosomal dominant inheritance;Somatic mutation                                                                                1348
Autosomal recessive inheritance;Autosomal dominant inheritance                                                                  924
X-linked dominant inheritance;X-linked inheritance                                                                              521
X-linked recessive inheritance                                                                                                  490
Autosomal dominant inheritance;Sporadic                                                                                         319
Autosomal recessive inheritance;Mitochondrial inheritance                                                                       319
Somatic mutation                                                                                                                286
Autosomal dominant inheritance;Autosomal recessive inheritance;Other                                                            221
Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic                                                         218
Sporadic                                                                                                                        194
Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance                                             188
Autosomal recessive inheritance;X-linked inheritance                                                                            118
Autosomal recessive inheritance;Codominant                                                                                      102
X-linked inheritance;X-linked recessive inheritance                                                                             100
Autosomal dominant inheritance;X-linked dominant inheritance                                                                     96
Somatic mutation;Autosomal dominant inheritance                                                                                  91
Autosomal dominant inheritance;Autosomal unknown;Autosomal recessive inheritance                                                 91
Mitochondrial inheritance                                                                                                        78
Sporadic;Autosomal recessive inheritance;Autosomal dominant inheritance                                                          62
Autosomal recessive inheritance;Autosomal dominant inheritance;Sporadic                                                          58
Autosomal dominant inheritance;Sporadic;Autosomal recessive inheritance                                                          55
Sporadic;Autosomal dominant inheritance;Autosomal recessive inheritance                                                          52
Autosomal dominant inheritance;X-linked inheritance                                                                              51
Autosomal recessive inheritance;Sporadic;Autosomal dominant inheritance                                                          49
Autosomal unknown                                                                                                                39
Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic;X-linked dominant inheritance;X-linked inheritance       32
Autosomal recessive inheritance;Autosomal dominant inheritance;Autosomal unknown                                                 29
X-linked dominant inheritance                                                                                                    26
X-linked inheritance;Autosomal recessive inheritance                                                                             19
Sex-limited autosomal dominant;Autosomal recessive inheritance                                                                   18
X-linked dominant inheritance;X-linked recessive inheritance                                                                     18
Autosomal recessive inheritance;Sex-limited autosomal dominant                                                                   16
X-linked dominant inheritance;X-linked inheritance;Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic       16
Autosomal dominant inheritance;Autosomal unknown                                                                                 14
Sex-limited autosomal dominant                                                                                                   13
Autosomal dominant inheritance;Autosomal recessive inheritance;Autosomal unknown                                                  9
Sporadic;Autosomal dominant inheritance                                                                                           9
Other                                                                                                                             7
Autosomal dominant inheritance;Somatic mutation;Autosomal recessive inheritance                                                   6
Autosomal dominant inheritance;Autosomal recessive inheritance;Somatic mutation                                                   4
Somatic mutation;Autosomal dominant inheritance;Autosomal recessive inheritance                                                   4
X-linked inheritance;Autosomal recessive inheritance;X-linked recessive inheritance                                               3
X-linked recessive inheritance;Autosomal dominant inheritance                                                                     2
Autosomal dominant inheritance;Mitochondrial inheritance                                                                          1
Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance;Autosomal dominant inheritance                1
Autosomal dominant inheritance;X-linked inheritance;Autosomal recessive inheritance                                               1
Autosomal recessive inheritance;Autosomal dominant inheritance;X-linked inheritance                                               1
Somatic mutation;Autosomal dominant inheritance;Autosomal unknown                                                                 1
Somatic mutation;Sporadic;Autosomal dominant inheritance                                                                          1
Autosomal dominant inheritance;Autosomal unknown;Somatic mutation                                                                 1
Autosomal dominant inheritance;Autosomal recessive inheritance;Mitochondrial inheritance                                          1
Sporadic;Somatic mutation;Autosomal dominant inheritance                                                                          1
Autosomal recessive inheritance;Codominant;X-linked inheritance;X-linked recessive inheritance                                    1
Name: inheritance_modes, dtype: int64
================
column 32: age_of_onset
Infancy                                        22811
All ages                                       22284
Childhood                                      16290
Adult                                           7878
Adolescent                                      7689
Antenatal                                       6877
Neonatal                                        5742
Adolescent;All ages                             1856
Neonatal/infancy                                 626
Adult;Childhood                                  318
Adolescent;Childhood                             317
Infancy;Neonatal;Neonatal/infancy                311
Childhood;Adult                                  295
Childhood;Infancy                                289
Infancy;Childhood                                256
Adolescent;Infancy                               233
All ages;Childhood                               212
Infancy;Neonatal                                 187
Neonatal;Infancy                                 187
Childhood;Adolescent                             172
All ages;Neonatal                                146
Adult;All ages                                   139
Childhood;Adult;Adolescent;All ages              129
Infancy;Adolescent                               122
All ages;Adult                                   118
Adult;Infancy                                    115
Adolescent;All ages;Childhood;Adult              113
Adult;Childhood;Adolescent;All ages              109
Childhood;All ages                               106
All ages;Childhood;Neonatal                      105
                                               ...  
All ages;Childhood;Adult;Adolescent                1
Adolescent;Variable;Childhood                      1
Childhood;All ages;Adolescent;Adult                1
Antenatal;Adult;Infancy;All ages                   1
Adult;Neonatal/infancy;Infancy                     1
All ages;Childhood;Antenatal                       1
Adult;All ages;Adolescent                          1
Childhood;All ages;Adolescent                      1
Infancy;Adult;All ages                             1
Infancy;Childhood;Adolescent                       1
Infancy;Adolescent;Adult;Childhood                 1
Adult;Infancy;Childhood                            1
Childhood;Adult;Infancy                            1
Neonatal;Adolescent                                1
Antenatal;Adolescent;Neonatal/infancy              1
Adult;Adolescent;All ages;Childhood                1
Neonatal;Childhood;Infancy;Antenatal               1
Childhood;Neonatal;Infancy;Antenatal               1
Infancy;Childhood;Neonatal;Neonatal/infancy        1
Childhood;Infancy;Adult;All ages                   1
Adolescent;Adult;Childhood;Infancy                 1
Adult;Neonatal                                     1
Childhood;Infancy;Adolescent                       1
All ages;Infancy;Adolescent;Adult                  1
Adolescent;Infancy;All ages;Adult                  1
Childhood;Neonatal;Variable;All ages;Adult         1
Childhood;Infancy;Antenatal;Neonatal               1
Adult;Childhood;Infancy                            1
Antenatal;Infancy;All ages;Adult                   1
Adolescent;Adult;Childhood                         1
Name: age_of_onset, dtype: int64
================
column 33: prevalence
<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              24930
1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               18647
1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             14698
1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 6284
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               6111
1-9 / 100 000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 2148
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1524
http://www.ncbi.nlm.nih.gov/books/NBK1247/;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1231
1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1192
http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1178
2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1096
1-5 / 10 000;1:3,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1049
1-9 / 1 000 000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                579
>1 / 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     476
1-9 / 100 000;Prevalence in Finland is at least 9:100,000 individuals.;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         394
<1 / 1 000 000;1-9 / 100 000;Prevalence in Finland is at least 9:100,000 individuals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         387
<1 / 1 000 000;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  335
1-9 / 100 000;Rett syndrome is an X linked condition that occurs in 1 in 10,000 to 1 in 15,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   303
1-9 / 100 000;CHARGE syndrome is an autosomal dominant condition that occurs in 1 in 12,000 live births.;CHARGE syndrome occurs in at least one in 10,000 births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             292
1-9 / 100 000;CdLS occurs in 1 in 10-100,000 live births.;Cornelia de Lange syndrome occurs in 1 in 10-100,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   283
1-5 / 10 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  255
<1 / 1 000 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                253
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            250
1-9 / 1 000 000;Hennekam et al [1990b] reported a birth prevalence of 1:100,000 to 1:125,000 for RSTS in the Netherlands.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     236
1-9 / 100 000;Wilson disease is an autosomal recessive disorder with a prevalence of 1/30,000, and a carrier frequency of 1/90.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               233
1/15 000;1:15,000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              232
1 per million;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  225
1-9 / 100 000;Sotos syndrome is an autosomal dominant condition that occurs in 1 in 14,000 live births.;Sotos syndrome occurs in 1 in 14,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     210
1-9 / 100 000;<1 / 1 000 000;Prevalence in Finland is at least 9:100,000 individuals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         207
1 in 5,000 male live births;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     201
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ...  
1-5 / 10 000;Risk of 40%-80% for breast cancer  1:400                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1
<1 / 1 000 000;The overall prevalence of hereditary neuropathies is estimated at approximately 3:10,000 population. About 30% of these individuals (1:10,000) may have CMT2. The prevalence of the various subtypes of CMT2 is unknown;Currently, CMT4A is considered the most frequent of all autosomal recessive forms of CMT.    Molecular genetic testing has shown that the following proportion of individuals with CMT have two disease-causing GDAP1 alleles:    1% - 15% individuals depending on the studied population                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1
1:8,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
1-5 / 10 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
<1 / 1 000 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000;1-9 / 1 000 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;1-9 / 1 000 000;1/35000;The prevalence of MEN 2 has been estimated at 1:35,000 [DeLellis et al 2004].;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1
1-9 / 1 000 000;1-9 / 100 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
1-9 / 1 000 000;6-9 / 10 000;<1 / 1 000 000;1-9 / 100 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
1-9 / 1 000 000;2:100.000;2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;1-9 / 1 000 000;http://www.ncbi.nlm.nih.gov/books/NBK1247/;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                    1
1-9 / 1 000 000;1-5 / 10 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;Risk of 40%-80% for breast cancer  1:400                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
1-9 / 100 000;Rett syndrome is an X linked condition that occurs in 1 in 10,000 to 1 in 15,000 live births.;The prevalence of AS is one in 12,000-20,000 population;The prevalence of AS is one in 12,000-20,000 population.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
1-9 / 1 000 000;Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1
1-5 / 10 000;1-9 / 100 000;6-9 / 10 000;<1 / 1 000 000;Beta-thalassemia is one of the most common autosomal recessive disorders worldwide.  10% depending on the studied population                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1
1-5 / 10 000;1/20,000 births (in all ethnic groups);1/20,000 births in general population                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
20210G>A heterozygosity occurs in 1.7%-3% of the general US and European populations: in the US, the prevalence of 20210G>A heterozygosity is 2%-5% in whites and 0%-0.3% in African Americans: among adults with VTE, 20210G>A heterozygosity is present in 6%-14% of those with a first VTE, and 18%-21% of those with a personal or family history of recurrent VTE: the prevalence of 20210G>A homozygosity is approximately one in 10,000. Double heterozygosity for the 20210G>A and factor V Leiden alleles occurs in approximately one in 1000 individuals in the general population and 2%-4.5% of persons with VTE;The prevalence of the G20210A in the general population is estimated to be 2.0%.     The prevalence of the G20210A substitution varies by ethnicity. It is most common in Europeans. the incidence is approximately 3.0% in southern Europeans, and 1.7% in northern Europeans. G20210A appears to be very rare in individuals of Asian and African descent.;<1 / 1 000 000        1
1-9 / 1 000 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1
Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
<1 / 1 000 000;1-9 / 1 000 000;Estimates range from 1:250,000 to 1:50,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
1-5 / 10 000;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
Risk of 40%-80% for breast cancer  1:400;2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
1-5 / 10 000;males affected with fragile X syndrome: 16 to 25:100,000  females affected with fragile X syndrome: approximately one-half the males prevalence  Unaffected female FMR1 carriers: 1:113 to 1:259  Females with FMR1-related POF: 4%-6% of all cases of 46,XX,POI  FXTAS males: an estimated 2%-4% of men with adult-onset cerebellar ataxia who represent simplex cases have a premutation in FMR1.;males affected with fragile X syndrome: 1:2,564 to 1:6,250  females affected with fragile X syndrome: approximately one-half the males prevalence  Unaffected female FMR1 carriers: 1:113 to 1:382  Females with FMR1-related POF: 1:7 (1:15 for the general population)                                                                                                                                                                                                                                                                                                                       1
<1 / 1 000 000;1-9 / 100 000;1-5 / 10 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
<1 / 1 000 000;The estimated incidence of permanent neonatal diabetes ranges from 1:215,000 to 1:260,000 live births                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
1-9 / 1 000 000;1 in 248,000 (combined Niemann-Pick A/B)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
1-9 / 100 000;1-5 / 10 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
<1 / 1 000 000;1-9 / 1 000 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
Name: prevalence, dtype: int64
================
column 34: disease_mechanism
loss of function                                                                                                                                                                          29766
gain of function                                                                                                                                                                           1952
Disease mechanisms vary by gene.                                                                                                                                                            854
gain of function;loss of function                                                                                                                                                           199
Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function                                       190
loss of function;gain of function                                                                                                                                                           149
Affects gamma-sarcoglycan and also disrupts the integrity of the entire sarcoglycan complex.                                                                                                137
Other                                                                                                                                                                                       106
May be benign                                                                                                                                                                                63
unknown                                                                                                                                                                                      33
Disease mechanisms vary by gene.;loss of function                                                                                                                                             5
gain of function;Disease mechanisms vary by gene.                                                                                                                                             2
Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function;Disease mechanisms vary by gene.        1
Dominant Negative                                                                                                                                                                             1
Name: disease_mechanism, dtype: int64
================
column 35: origin
germline                                        262256
not provided                                      7585
unknown                                           7047
germline;unknown                                  5146
somatic                                           2495
germline;not provided                             2439
de novo                                           1082
not provided;germline                             1042
unknown;germline                                   865
inherited                                          594
maternal                                           375
germline;somatic                                   272
de novo;germline                                   264
germline;not provided;unknown                      253
not provided;unknown                               221
paternal                                           208
germline;inherited                                 201
germline;de novo                                   159
somatic;germline                                   134
germline;maternal                                  119
germline;paternal                                  104
germline;unknown;not provided                       51
not provided;germline;unknown                       50
not applicable                                      49
germline;maternal;unknown                           43
inherited;germline                                  43
not provided;unknown;germline                       36
de novo;germline;unknown                            34
de novo;unknown                                     32
germline;not applicable                             31
                                                 ...  
germline;de novo;inherited                           1
germline;not applicable;inherited;unknown            1
unknown;germline;de novo                             1
unknown;germline;not provided                        1
germline;maternal;unknown;not provided               1
not provided;germline;unknown;maternal               1
somatic;germline;maternal;paternal                   1
de novo;not provided;unknown                         1
not provided;de novo;germline;unknown                1
de novo;not provided                                 1
not-reported                                         1
germline;paternal;unknown;de novo                    1
germline;somatic;not provided;unknown                1
de novo;somatic                                      1
not provided;inherited;germline                      1
germline;somatic;paternal;unknown                    1
germline;unknown;de novo;maternal                    1
somatic;germline;not provided;unknown                1
unknown;maternal                                     1
unknown;germline;de novo;somatic                     1
germline;somatic;de novo                             1
germline;not provided;biparental                     1
germline;not applicable;not provided;unknown         1
germline;unknown;maternal;de novo;inherited          1
germline;de novo;unknown;somatic                     1
germline;not applicable;somatic                      1
inherited;maternal;not provided                      1
maternal;not provided;unknown                        1
germline;unknown;inherited                           1
germline;not provided;unknown;inherited              1
Name: origin, dtype: int64
